HomeComparePBMRY vs MRK

PBMRY vs MRK: Dividend Comparison 2026

PBMRY yields 37.11% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PBMRY wins by $141.0K in total portfolio value
10 years
PBMRY
PBMRY
● Live price
37.11%
Share price
$5.39
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$197.8K
Annual income
$31,387.75
Full PBMRY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — PBMRY vs MRK

📍 PBMRY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPBMRYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PBMRY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PBMRY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PBMRY
Annual income on $10K today (after 15% tax)
$3,153.99/yr
After 10yr DRIP, annual income (after tax)
$26,679.59/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, PBMRY beats the other by $18,351.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PBMRY + MRK for your $10,000?

PBMRY: 50%MRK: 50%
100% MRK50/50100% PBMRY
Portfolio after 10yr
$127.3K
Annual income
$20,592.95/yr
Blended yield
16.18%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PBMRY
No analyst data
Altman Z
5.4
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PBMRY buys
0
MRK buys
0
No recent congressional trades found for PBMRY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPBMRYMRK
Forward yield37.11%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$197.8K$56.8K
Annual income after 10y$31,387.75$9,798.13
Total dividends collected$145.4K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PBMRY vs MRK ($10,000, DRIP)

YearPBMRY PortfolioPBMRY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$14,411$3,710.58$11,206$366.19+$3.2KPBMRY
2$20,417$4,997.34$12,650$502.35+$7.8KPBMRY
3$28,463$6,616.96$14,407$694.19+$14.1KPBMRY
4$39,076$8,621.19$16,585$967.82+$22.5KPBMRY
5$52,873$11,061.66$19,342$1,363.89+$33.5KPBMRY
6$70,563$13,988.12$22,913$1,947.19+$47.6KPBMRY
7$92,949$17,446.70$27,662$2,823.89+$65.3KPBMRY
8$120,933$21,478.21$34,159$4,173.35+$86.8KPBMRY
9$155,515$26,116.62$43,337$6,308.80+$112.2KPBMRY
10$197,789$31,387.75$56,776$9,798.13+$141.0KPBMRY

PBMRY vs MRK: Complete Analysis 2026

PBMRYStock

PT Bumi Resources Tbk, together with its subsidiaries, engages in the mining activities in Indonesia. It operates through Holding Company, Coal, Services, Oil and Gas, and Gold segments. The Coal segment engages in the exploration, exploitation, mining, and sale of coal deposits. The Services segment offers marketing and management services. The Oil and Gas segment explores for oil and gas properties. The Gold segment explores for gold properties. The company also exports its products. PT Bumi Resources Tbk was formerly known as PT Bumi Modern Tbk. and changed its name to PT Bumi Resources Tbk in September 2000. PT Bumi Resources Tbk was founded in 1973 and is headquartered in Jakarta Selatan, Indonesia.

Full PBMRY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PBMRY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PBMRY vs SCHDPBMRY vs JEPIPBMRY vs OPBMRY vs KOPBMRY vs MAINPBMRY vs JNJPBMRY vs ABBVPBMRY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.